Literature DB >> 15459089

Distribution spectrum of paraoxonase activity in HDL fractions.

Christoph Bergmeier1, Rüdiger Siekmeier, Werner Gross.   

Abstract

BACKGROUND: Paraoxonase (PON1) associated with HDL can be regarded as a cardio- and vasoprotective enzyme. However, because HDL is not a homogeneous fraction, it is important to investigate in which subgroups of HDL active PON1 is located. It would also be useful to determine density profiles of the HDL apolipoproteins (Apo) E and J.
METHODS: We investigated the density range of HDL (rho = 1.063-1.256 kg/L) in healthy individuals, using the ultracentrifugation reference method and a newly introduced automated fractionation method. Profiles of PON1 activity and ApoA-I, ApoA-II, ApoE, ApoJ, and cholesterol concentrations were obtained by use of various density gradients.
RESULTS: PON1 activity was highest in the more dense HDL(3) and VHDL fractions where PON1 was not dissociated from the particles during centrifugation. The fraction in density range 1.175-1.185 kg/L showed not only the highest PON1 activity, but also the highest specific activity (activity per HDL particle). This fraction was the least-dense fraction containing both ApoE and ApoJ. Only the Q192R polymorphism had an effect on the distribution profile of PON1 activity. In contrast, L55M and the T(-107)C polymorphisms (determined by a novel nonradioactive method) were without effect on the density distribution of PON1 activity.
CONCLUSION: The HDL(3) fraction, which is important in reverse cholesterol transport, also carries the highest PON1 activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459089     DOI: 10.1373/clinchem.2004.034439

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

2.  Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease.

Authors:  Imteyaz Ahmad; Rajiv Narang; Anand Venkatraman; Nibhriti Das
Journal:  J Community Genet       Date:  2011-02-07

3.  Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome.

Authors:  James Kyle Taylor; Eric P Plaisance; A Jack Mahurin; Michael L Mestek; Jose Moncada-Jimenez; Peter W Grandjean
Journal:  Redox Rep       Date:  2014-09-02       Impact factor: 4.412

4.  Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.

Authors:  Yuepeng Jin; Qiang Li; Junjun Qiu; Xiufen Zhao; Chunxiao Zheng; Shixu Lv; Yongyu Bai; Yunfeng Shan; Le-Chi Ye
Journal:  Tumour Biol       Date:  2016-08-23

5.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

Review 6.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats.

Authors:  Tayibeh Ghaffari; Mohammad Nouri; Ebrahim Irannejad; Mohammad-Reza Rashidi
Journal:  Bioimpacts       Date:  2011-08-04

8.  Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

Authors:  W Sean Davidson; R A Gangani D Silva; Sandrine Chantepie; William R Lagor; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

9.  Lipid-modulating treatments for mixed dyslipidemia increase HDL-associated phospholipase A2 activity with differential effects on HDL subfractions.

Authors:  Anastazia Kei; Evangelos Liberopoulos; Costantinos Tellis; Moses Elisaf; Alexandros Tselepis
Journal:  Lipids       Date:  2013-08-15       Impact factor: 1.880

10.  PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.

Authors:  Oscar Zaragoza-García; Iris Paola Guzmán-Guzmán; Ma Elena Moreno-Godínez; José Eduardo Navarro-Zarza; Verónica Antonio-Vejar; Mónica Ramírez; Isela Parra-Rojas
Journal:  Clin Rheumatol       Date:  2020-06-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.